$133.66
-4.02-2.92%
At close: May 6, 5:00 PM EST
$133.96
-3.72-2.70%
Pre-Market: 4:32 AM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
6.26B
Fund Score
Loading...
Key Statistics
Open
-
High
-
52 Wk High
$139.19
AUM
6.26B
Dividend
$0.26
Ex-Div Date
Jun 24, 2024
Volume
1.36K
Market Cap
$21.72B
Mgmt Fee
0.35%
P/E Ratio
15.01
Prev. Close
$137.68
Low
-
52 Wk Low
$75.68
Shares Out
75.22M
Yield
0.27%
Div. Freq
Quarterly
Avg. Volume Daily
8.45M
Beta
0.95
Avg. Expense Ratio
0.35%
P/B Ratio
3.29
Recent SPDR Series Trust - SPDR S&P Biotech ETF News
FAQ
Q
How do I buy State Street SPDR S&P Biotech ETF (XBI) stock?
A
You can purchase shares of State Street SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.
Q
Who are State Street SPDR S&P Biotech ETF (XBI) competitors?
A
There are no as such competitors for State Street SPDR S&P Biotech ETF.
Q
What is the forecast, or price target, for State Street SPDR S&P Biotech ETF (XBI) stock?
A
There is no analysis for State Street SPDR S&P Biotech ETF to provide a consensus price target.
Q
What is the current price for State Street SPDR S&P Biotech ETF (XBI)?
A
The stock price for State Street SPDR S&P Biotech ETF (ARCA: XBI) is $133.96 last updated May 8, 2026 at 4:02 AM EDT.
Q
Does State Street SPDR S&P Biotech ETF (XBI) pay a dividend?
A
There are no upcoming dividends for State Street SPDR S&P Biotech ETF.
Q
When is State Street SPDR S&P Biotech ETF (ARCA:XBI) reporting earnings?
A
State Street SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.
Q
Is State Street SPDR S&P Biotech ETF (XBI) going to split?
A
There is no upcoming split for State Street SPDR S&P Biotech ETF.
Key Statistics
Open
-
High
-
52 Wk High
$139.19
AUM
6.26B
Dividend
$0.26
Ex-Div Date
Jun 24, 2024
Volume
1.36K
Market Cap
$21.72B
Mgmt Fee
0.35%
P/E Ratio
15.01
Prev. Close
$137.68
Low
-
52 Wk Low
$75.68
Shares Out
75.22M
Yield
0.27%
Div. Freq
Quarterly
Avg. Volume Daily
8.45M
Beta
0.95
Avg. Expense Ratio
0.35%
P/B Ratio
3.29
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Small Cap Blend |
| Fund Inception | Jan 31, 2006 |
| Managers | Raymond Donofrio Karl A. Schneider |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| NVAX | Novavax Inc | 3.06% |
| INSM | Insmed Inc | 3.19% |
| MRNA | Moderna Inc | 2.04% |
| NTRA | Natera Inc | 2.47% |
| DYN | Dyne Therapeutics Inc | 1.33% |
| RVMD | Revolution Medicines I... | 1.32% |
| PTCT | Ptc Therapeutics Inc | 1.29% |
| BPMC | Blueprint Medicines Co... | 2.47% |
| UTHR | United Therapeutics Co... | 1.99% |
| AMGN | Amgen Inc | 1.93% |
| GILD | Gilead Sciences Inc | 2.51% |
| ABBV | Abbvie Inc | 2.08% |
| BMRN | Biomarin Pharmaceutica... | 2.47% |
| VRTX | Vertex Pharmaceuticals... | 1.87% |
| INCY | Incyte Corp | 2.81% |
| ALNY | Alnylam Pharmaceutical... | 3.51% |
| HALO | Halozyme Therapeutics ... | 3.13% |
| BIIB | Biogen Inc | 1.95% |
| NBIX | Neurocrine Biosciences... | 2.59% |
| EXAS | Exact Sciences Corp. | 3.22% |
| EXEL | Exelixis Inc | 1.97% |
| REGN | Regeneron Pharmaceutic... | 1.94% |
| MDGL | Madrigal Pharmaceutica... | 1.88% |
| BBIO | Bridgebio Pharma Inc | 2.49% |
| SM | Crispr Therapeutics Ag | 2.28% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved